The updated Good Publication Practice (GPP) guideline for communicating company-sponsored medical research, GPP3, has now been published. Liz Wager, publications consultant and co-author, shares the details and reflects on the changing landscape of publications management.

Recorded 21 August 2015 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

ABSTRACT:

The updated Good Publication Practice guideline, GPP3, has a broader international authorship than previous GPP guidelines, and a more confident tone. It has new sections on the principles of GPP, studies that should be published, plagiarism, and data sharing, and clearer guidelines on authorship. The ten new principles of GPP should be useful for training and promotion, and should help to shape and determine future recommendations. There is a stronger commitment to the principle that companies should publish all trials, while specific guidelines, for example regarding timely publication within 12 months of study completion, are in line with industry standards. Guidelines on payments to authors are clarified, along with those on authorship. The latter flesh out the criteria set down by the International Committee of Medical Journal Editors (ICJME) in stressing, for example, that ‘Authorship must represent a substantial contribution to both the research being reported and [to] the… publication’. The new section on data sharing recommends that sponsors grant access to patient-level data to qualified researchers on request, redacted as appropriate to protect patient confidentiality, even if this is not required by a journal. Likewise, trial registration numbers should be included, even if they are not required by a journal or congress, and publication steering committees should consider forming an authorship working group to ensure appropriate and transparent authorship decisions.

GPP3 is freely available via the Annals of Internal Medicine website, see: Good publication practice guideline: GPP3. Citation: Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Ann Intern Med. 2015; 163: 461-464. doi: 10.7326/M15-0288 See http://annals.org/aim/article/2424869/good-publication-practice-communicating-company-sponsored-medical-research-gpp3

Written by Penny Gray, Freelance Medical Writer

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts, like this one, for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new topics and speakers.

Full details of this MedComms Networking event are at http://medcommsnetworking.com/event67b.html

Liz’s presentation (PDF format) is at http://medcommsnetworking.com/presentations/wager_210815.pdf

Liz’s Linkedin page is at https://www.linkedin.com/in/liz-wager-0124597/

More about Liz Wager can be found at http://www.lizwager.com

Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]